Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Cartagenia enters partnership for rare epilepsy syndromes

March 20, 2012

Thrombogenics and Alcon enter commercialization agreement for ocriplasmin

March 16, 2012

Biogen Idec and MAKScientific enter MS agreement

March 16, 2012

Almirall attains new marketing rights to Sativex

March 16, 2012

Marina Biotech and ProNAi Therapeutics enter license agreement for DNAi-based therapies

March 16, 2012

Horizon Discovery and RFUMS to develop human cellular CF model

March 16, 2012

BioFocus, Argenta and AstraZeneca enter new research agreement

March 15, 2012

Epistem and GlaxoSmithKline enter biomarker collaboration

March 14, 2012

Immunovaccine and Weill Cornell Medical College join to develop anticocaine vaccine

March 13, 2012

Amorfix announces new technology acquisition

March 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...